The startup develops a medical device that enables surgeons to safely and effectively excise excessive eyelid skin while minimizing bleeding, bruising, and swelling. This technology enhances patients' peripheral vision and provides a rejuvenated appearance, allowing for a quicker return to daily activities.
Funding
$4.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional blepharoplasty, or eyelid lift surgery, often involves lengthy procedures, potential complications, and extended recovery times due to bleeding, bruising, and the need for sutures. This can deter both surgeons and patients from opting for this vision and appearance-enhancing procedure.
Solution
OSHERU is addressing these issues with Ziplyft, a patented FDA Class 1 medical device designed for minimally invasive eyelid surgery (MIS-4-Lids). The device allows surgeons to perform blepharoplasties in-office in under 15 minutes, without the need for IV sedation, cautery, or sutures. Ziplyft features a clear design for visual precision, serrated jaws to compress and seal the skin, a guarded blade for accurate excision, and a zipper-lock closure that enables tension-free gluing of the skin. This approach minimizes bleeding and bruising, reduces operative time, and promotes faster patient recovery, leading to improved peripheral vision and a rejuvenated appearance.
Target Audience
The primary target audience includes ophthalmologists, oculoplastic surgeons, and patients seeking a less invasive and more efficient solution for addressing excess eyelid skin and improving peripheral vision.
Features
- Patented FDA Class 1 device designed for minimally invasive eyelid surgery
- Clear plastic construction providing direct visualization of skin markings
- Serrated jaws compressing and sealing skin to minimize bleeding and bruising
- Integrated guarded blade for precise and symmetric skin removal
- Zipper-lock closure enabling sutureless wound closure with tissue glue
- Procedure can be performed in-office, eliminating the need for a hospital or surgery center
- Reduced operative time, typically less than 15 minutes
- No need for IV sedation or cautery